An Overview of ASCP
The American Society of Clinical Psychopharmacology (ASCP) was founded in 1992 to advance the science and practice of clinical psychopharmacology. Its nearly 1,000 members are physicians who study and practice psychopharmacology, as well as doctoral level investigators of clinical psychopharmacology or of pharmacology. ASCP members are advocates for clinical psychopharmacology and for clinical research.
ASCP has about 1,000 members, most of whom live in the United States. It is headquartered in Brentwood, Tennessee. The Society has four major meetings per year. The Fall and Spring Update on Psychopharmacology: State of the Art meetings (East and West coast) bring together a number of outstanding psychopharmacologists to speak and dialogue with meeting participants. For over 50 years, the ASCP Annual Meeting (formerly know as NCDEU) has featured emerging research in the field of psychopharmacology and brings together over 1200 academic and industry investigators, research pharmacists, and clinicians. Finally, ASCP co-sponsors with NIMH and the Zucker Hillside Hospital an annual Workshop on Clinical Trials. This intensive two day workshop is the “how to” of designing and running clinical trials.
ASCP’s official journal is the Journal of Clinical Psychiatry, with the largest circulation in psychiatry. ASCP also partners with Biological Therapies in Psychiatry, and members receive a discounted rate on this excellent newsletter.
Because education is a primary focus of the society, ASCP has developed a Model Curriculum in Psychopharmacology for Psychiatry Residency Training. The Curriculum is now in its 8th edition, and is widely used in the United States and internationally. A version for medical student educators and a primary care version were recently released.
ASCP invites you to learn more about our Society and programs by exploring this web site, and invites you to attend one or more of our excellent meetings.